GASTROESOPHAGEAL ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat stomach cancers in major trial
Disease control Recruiting nowThis study is testing if adding a new drug called zanidatamab to the standard two-drug treatment works better to control advanced stomach and esophageal cancer that has a specific marker (HER2-positive). It will involve 168 adults whose cancer has worsened despite previous treatm…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Apr 01, 2026 23:10 UTC
-
New hope for advanced stomach cancer: experimental drug cocktail trial opens
Disease control Recruiting nowThis study is testing new drug combinations for people with advanced stomach or esophageal cancer that cannot be removed by surgery. Researchers will give 160 participants experimental drugs along with standard chemotherapy and immunotherapy to see if they are safe and effective.…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Custom-Made vaccine aims to train immune system to hunt down hidden cancer
Disease control Recruiting nowThis is an early-stage safety study for a new type of personalized cancer vaccine. It is for patients with bladder or stomach cancer who have had surgery but still have tiny traces of cancer DNA in their blood, putting them at high risk for the cancer coming back. The goal is to …
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Blood test guides aggressive attack on spreading stomach and pancreatic cancers
Disease control Recruiting nowThis study is for people with advanced cancer that started in the upper digestive tract (like the stomach, pancreas, or bile ducts) and has spread to only a few other places. After three months of chemotherapy, if a special blood test finds no cancer DNA, patients are randomly as…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
AstraZeneca launches Multi-Drug attack on stomach cancer before surgery
Disease control Recruiting nowThis study is testing several new drug combinations given before and after surgery for people with advanced but removable stomach or esophageal cancer. The main goals are to see if these treatments are safe and if they can shrink or eliminate the tumor before it is surgically rem…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for tough stomach cancers: first human trial begins
Disease control Recruiting nowThis early-stage study is testing a new drug called BDC-4182 for people with advanced stomach or esophageal cancer that has spread or can't be removed by surgery. The main goals are to find the safest dose and see how well the body handles the drug. Researchers will also check if…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough stomach cancers: trial tests Cutting-Edge drug combos
Disease control Recruiting nowThis study is testing whether adding new targeted drugs to standard chemotherapy works better for people with advanced stomach or esophageal cancer that has worsened after initial treatment. It will enroll 210 participants to compare different drug combinations, focusing on safet…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Triple-Threat therapy tested for aggressive stomach cancers
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or esophageal cancer that has spread. It's for patients who have not yet received treatment for their advanced cancer and whose tumors test positive for two specific markers (HER2 and PD-L1). The …
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Blood test guides chemo in stomach cancer trial
Disease control Recruiting nowThis small, early-stage trial is testing if doctors can personalize chemotherapy for stomach cancer by using a special blood test to guide treatment. The goal is to see if adjusting the chemo based on how the cancer responds helps control the disease better before surgery. The st…
Matched conditions: GASTROESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC